Cargando…
Sex differences in gene expression with galactosylceramide treatment in Cln3(Δex7/8) mice
BACKGROUND: CLN3 disease is caused by mutations in the CLN3 gene. The purpose of this study is to discern global expression patterns reflecting therapeutic targets in CLN3 disease. METHODS: Differential gene expression in vehicle-exposed mouse brain was determined after intraperitoneal vehicle/Galac...
Autores principales: | Makoukji, Joelle, El-Sitt, Sally, Makhoul, Nadine J., Soueid, Jihane, Kadara, Humam, Boustany, Rose-Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531864/ https://www.ncbi.nlm.nih.gov/pubmed/33006978 http://dx.doi.org/10.1371/journal.pone.0239537 |
Ejemplares similares
-
Developmental Comparison of Ceramide in Wild-Type and Cln3(Δex7/8) Mouse Brains and Sera
por: El-Sitt, Sally, et al.
Publicado: (2019) -
Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients
por: Makoukji, Joelle, et al.
Publicado: (2015) -
Exogenous Flupirtine as Potential Treatment for CLN3 Disease
por: Maalouf, Katia, et al.
Publicado: (2020) -
RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism
por: Soueid, Jihane, et al.
Publicado: (2016) -
Glycerophosphoinositol is Elevated in Blood Samples From
CLN3(Δex7-8) pigs,
Cln3(Δex7-8) Mice, and CLN3-Affected
Individuals
por: Brudvig, Jon J, et al.
Publicado: (2022)